ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2010

Aug 31, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2010-08-31

Reporting Person: Anzalone Christopher Richard (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-08-31	Common Stock	P	10000	$0.89	Acquired	341729	Direct